Aortic Aneurysm & Vascular Genetics

About this condition

Aortic Aneurysm / Vascular Genetics

Heritable thoracic aortic disease encompasses a group of conditions predisposing to thoracic aortic aneurysm and dissection (TAAD) — a life-threatening emergency where the aortic wall tears and causes massive bleeding. Approximately 20% of thoracic aortic aneurysms have a familial basis. FBN1 variants cause Marfan syndrome (prevalence approximately 1 in 5,000), which affects the aorta, eyes, and skeleton. TGFBR1 variants cause Loeys-Dietz syndrome, characterized by aggressive early-onset aortic disease, craniofacial features, and tissue friability. MYH11 variants cause familial non-syndromic TAAD, often with patent ductus arteriosus. All three follow autosomal dominant inheritance. Aortic dissection can occur without warning at aortic diameters considered safe in the general population — particularly in Loeys-Dietz syndrome, where aggressive aortic dilation and dissection can occur at relatively small aortic diameters.

FBN1 encodes fibrillin-1, a major structural component of extracellular matrix microfibrils; pathogenic variants weaken connective tissue and dysregulate transforming growth factor beta (TGF-β) signaling, causing progressive aortic root dilation. Over 3,000 FBN1 variants have been catalogued. TGFBR1 encodes a TGF-β type I receptor; loss-of-function variants paradoxically increase TGF-β signaling in the aortic wall, driving more aggressive aneurysm formation. MYH11 encodes smooth muscle myosin heavy chain; variants impair vascular smooth muscle cell contraction, compromising aortic wall integrity. Eleven genes total have confirmed high-penetrance TAAD risk, but three — FBN1, TGFBR1, and MYH11 — account for the majority of heritable cases.

Confirming a heritable aortic disease diagnosis transforms management into aggressive prevention. For FBN1-related disease, regular imaging (echocardiography or CT/MRI) monitors aortic root diameter; beta-blockers or angiotensin II receptor antagonists slow aortic dilation and delay dissection. Prophylactic aortic root replacement is offered when the aortic root reaches a diameter-specific threshold — typically 5.0–5.5 cm for FBN1, but much smaller (~5.0 cm) for TGFBR1 because dissection risk is higher at smaller diameters. Gene-specific thresholds are critical: using the wrong criterion delays necessary surgery and increases sudden death risk. Identifying a pathogenic variant enables cascade testing of relatives, informing imaging surveillance and surgical planning. Activity restriction (avoiding strenuous sports) is advised.

FBN1, TGFBR1, and MYH11 variants have distinct phenotypes and surgery thresholds — FBN1 typically milder, TGFBR1 more aggressive with lower dissection threshold, MYH11 non-syndromic TAAD.

Gene locus: FBN1 (15q21.1), TGFBR1 (9q22.33), MYH11 (16p13.11)

Standard TAAD panels test 11–20 genes but identify mutations in only ~30% of familial non-syndromic thoracic aortic disease.

Most familial thoracic aortic disease remains genetically unresolved

TAAD panels typically test 11–20 genes associated with heritable aortic disease. However, identifiable mutations in known genes account for only approximately 30% of familial non-syndromic TAAD. FBN1 and Loeys-Dietz genes (TGFBR1, TGFBR2) together account for only approximately 10% of familial TAAD. ACTA2 (smooth muscle alpha-actin) accounts for 12–21%; MYH11 and others for smaller fractions. The majority of familial TAAD remains genetically unexplained, suggesting undiscovered genes, oligogenic inheritance, or polygenic contributions. Whole genome sequencing enables both rare variant detection and genome-wide risk score calculation.

A finding determines surgical thresholds and prevents dissection

When a pathogenic aortic disease variant is confirmed, gene-specific surgical thresholds become critical for preventing sudden death. FBN1-related disease typically warrants prophylactic surgery at aortic root diameter 5.0–5.5 cm; Loeys-Dietz syndrome (TGFBR1) warrants prophylactic surgery at much smaller diameters (~5.0 cm or even smaller) because of higher dissection risk at smaller sizes. Using the wrong threshold — basing surgery decisions on general population guidelines rather than gene-specific criteria — delays necessary intervention. Cascade testing identifies at-risk relatives before their first imaging study, enabling lifelong surveillance and preventing sudden aortic dissection through preventive surgery.

You were told your aorta is larger than expected. Or that a relative needed emergency vascular surgery. The answer to why may be written in a single gene.